Skip to content

Establishment and application of intelligent individualized diagnosis and treatment system for femoral head necrosis based on CJFH classification

Establishment and application of intelligent individualized diagnosis and treatment system for femoral head necrosis based on CJFH classification

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200067110
Enrollment
Unknown
Registered
2022-12-27
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteonecrosis of the femoral head

Interventions

Test group:Robot guided hip reserved surgery
Control group:traditional hip reserved surgery

Sponsors

China Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Avascular necrosis of the femoral head with indications of hip preservation surgery before ARCO IIIa; (2) Perform osteopathic robot navigation assisted femoral head core decompression and bone grafting or compression bone grafting.

Exclusion criteria

Exclusion criteria: (1) Patients with femoral head necrosis due to glucocorticoid use and who need to continue glucocorticoid treatment; (2) Patients who cannot tolerate general anesthesia due to systemic diseases such as heart and lung; (3) Patients with systemic infection or local skin infection around the incision.

Design outcomes

Primary

MeasureTime frame
Hip reserved rate of femoral head necrosis;

Countries

China

Contacts

Public ContactFuqiang Gao

China Japan Friendship Hospital

gaofuqiang@bjmu.edu.cn18901267995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026